Register | Login
Intellectual Property Today
RFC Express - Document Management System
2013 Top Patent Firms
2013 Top Trademark Firms
Current Issue

Advertising Opportunities

Click Here

Email A Friend Back to Archived News

MMI-USA Announces New Patent Applications, Stricter Protections of Device Designs

Thursday, May 06, 2010

Memphis, TN -- MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.

In addition to its current patents, Memometal has other pending patent applications including United States Patent Application No. 2008/0177262 directed to the Smart Toe® intramedullary implant and a United States Patent Application corresponding to WIPO Publication No. WO 2008/129214 directed to the X-Fuse® intramedullary implant. The company also recently acquired the patent and trademark rights in the United States for OrthoGlide® ankle implants.

“Our goal is to bring new products to the market that improve the surgeon’s clinical practice and most importantly, patient outcomes,” says Bernard Prandi, Memometal Technologies’ co-founder. “Because our products have been so successful both commercially and clinically, they are often the subject of copy attempts.”

Memometal intends to take immediate enforcement action. Legal counsel, Norris, McLaughlin & Marcus, PA has been retained to investigate and pursue these false claims.

“Strict patent and trademark enforcement are not only important to our business and industry, but to the surgeons and patients who rely on the quality and efficacy of our products,” says Prandi.

The company continues research and development on its rich new product pipeline, as well as on improving existing implant designs, which will form the basis for the future patent filings.

MMI-USA, Inc. ( is a leading provider of innovative, cost-effective orthopedic extremity solutions dedicated to enhancing the ability of physicians to deliver improved patient outcomes and quality of life through quality implants, clinical education and superior services. A subsidiary of Memometal Technologies S.A., headquartered in France, the company’s implant designs are highly regarded by surgeons worldwide for superior functionality and results. The company was recognized in 2008 as a Company of the Future by Ernst & Young, France. Contact MMI-USA by telephone at 901.685.7557 or via e mail at

Back to Archived News
Looking for...

  © Copyright 2013 Intellectual Property Today
Download Adobe Reader for free